Susannah Gray - Net Worth and Insider Trading
Susannah Gray Net Worth
The estimated net worth of Susannah Gray is at least $181,875 dollars as of 2024-11-13. Susannah Gray is the Director of Maravai LifeSciences Holdings Inc and owns about 31,852 shares of Maravai LifeSciences Holdings Inc (MRVI) stock worth over $181,875. Details can be seen in Susannah Gray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susannah Gray has not made any transactions after 2020-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susannah Gray
Susannah Gray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susannah Gray owns 4 companies in total, including 4D Molecular Therapeutics Inc (FDMT) , Morphic Holding Inc (MORF) , and Maravai LifeSciences Holdings Inc (MRVI) among others .
Click here to see the complete history of Susannah Gray’s form 4 insider trades.
Insider Ownership Summary of Susannah Gray
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FDMT | 4D Molecular Therapeutics Inc | 2020-12-10 | director |
MORF | Morphic Holding Inc | 2021-04-27 | director |
MRVI | Maravai LifeSciences Holdings Inc | 2020-11-24 | director |
2023-02-26 | director |
Susannah Gray Latest Holdings Summary
Susannah Gray currently owns a total of 1 stock. Susannah Gray owns 31,852 shares of Maravai LifeSciences Holdings Inc (MRVI) as of November 24, 2020, with a value of $181,875.
Latest Holdings of Susannah Gray
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRVI | Maravai LifeSciences Holdings Inc | 2020-11-24 | 31,852 | 5.71 | 181,875 |
Holding Weightings of Susannah Gray
Susannah Gray Form 4 Trading Tracker
According to the SEC Form 4 filings, Susannah Gray has made a total of 1 transactions in Maravai LifeSciences Holdings Inc (MRVI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Maravai LifeSciences Holdings Inc is the acquisition of 20,000 shares on November 24, 2020, which cost Susannah Gray around $540,000.
Insider Trading History of Susannah Gray
- 1
Susannah Gray Trading Performance
GuruFocus tracks the stock performance after each of Susannah Gray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susannah Gray is 27.5%. GuruFocus also compares Susannah Gray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susannah Gray within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susannah Gray's insider trading performs compared to the benchmark.
Performance of Susannah Gray
Susannah Gray Ownership Network
Ownership Network List of Susannah Gray
Ownership Network Relation of Susannah Gray
Susannah Gray Owned Company Details
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Susannah Gray is the director of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Susannah Gray made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 1,000 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 1,000 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
Susannah Gray Mailing Address
Above is the net worth, insider trading, and ownership report for Susannah Gray. You might contact Susannah Gray via mailing address: 10770 Wateridge Circle Suite 200, San Diego Ca 92121.